Annual Total Liabilities:
$413.82M+$223.55M(+117.50%)Summary
- As of today, RXRX annual total liabilities is $413.82 million, with the most recent change of +$223.55 million (+117.50%) on December 31, 2024.
- During the last 3 years, RXRX annual total liabilities has risen by +$346.41 million (+513.91%).
- RXRX annual total liabilities is now at all-time high.
Performance
RXRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$383.21M+$11.92M(+3.21%)Summary
- As of today, RXRX quarterly total liabilities is $383.21 million, with the most recent change of +$11.92 million (+3.21%) on June 30, 2025.
- Over the past year, RXRX quarterly total liabilities has increased by +$191.80 million (+100.20%).
- RXRX quarterly total liabilities is now -24.10% below its all-time high of $504.87 million, reached on December 1, 2020.
Performance
RXRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RXRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +117.5% | +100.2% |
| 3Y3 Years | +513.9% | +63.1% |
| 5Y5 Years | +1583.1% | - |
RXRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +513.9% | -7.4% | +144.6% |
| 5Y | 5-Year | at high | +1583.1% | -24.1% | +585.8% |
| All-Time | All-Time | at high | +1583.1% | -24.1% | +585.8% |
RXRX Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $383.21M(+3.2%) |
| Mar 2025 | - | $371.29M(-10.3%) |
| Dec 2024 | $413.82M(+117.5%) | $413.82M(+104.9%) |
| Sep 2024 | - | $201.94M(+5.5%) |
| Jun 2024 | - | $191.41M(+22.2%) |
| Mar 2024 | - | $156.70M(-17.6%) |
| Dec 2023 | $190.26M(-11.7%) | $190.26M(-1.3%) |
| Sep 2023 | - | $192.86M(-2.5%) |
| Jun 2023 | - | $197.74M(+0.3%) |
| Mar 2023 | - | $197.19M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $215.48M(+219.7%) | $215.48M(-3.6%) |
| Sep 2022 | - | $223.50M(-4.9%) |
| Jun 2022 | - | $234.94M(-2.4%) |
| Mar 2022 | - | $240.75M(+257.2%) |
| Dec 2021 | $67.41M(+19.2%) | $67.41M(+13.1%) |
| Sep 2021 | - | $59.57M(+6.6%) |
| Jun 2021 | - | $55.88M(-1.4%) |
| Mar 2021 | - | $56.66M(-88.8%) |
| Dec 2020 | $56.56M(+130.0%) | - |
| Dec 2020 | - | $504.87M |
| Dec 2019 | $24.59M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual total liabilities?
- What is the all-time high annual total liabilities for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual total liabilities year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual total liabilities?
The current annual total liabilities of RXRX is $413.82M
What is the all-time high annual total liabilities for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual total liabilities is $413.82M
What is Recursion Pharmaceuticals, Inc. annual total liabilities year-on-year change?
Over the past year, RXRX annual total liabilities has changed by +$223.55M (+117.50%)
What is Recursion Pharmaceuticals, Inc. quarterly total liabilities?
The current quarterly total liabilities of RXRX is $383.21M
What is the all-time high quarterly total liabilities for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly total liabilities is $504.87M
What is Recursion Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
Over the past year, RXRX quarterly total liabilities has changed by +$191.80M (+100.20%)